Asia’s fund selectors like slumping Chinese equities
In the next 12 months, allocations to China equity funds will be up while US and European equity exposure will decrease, according to data
Managers retain faith in EMs despite selector pessimism
Some fund managers maintain robust optimism about emerging markets over the long term despite slump in selector buying intentions
Long-term investment horizon key to reaping biotech returns
The biotech sector is going through a renaissance as innovation takes off according to one successful fund manager, but data shows that performance over the last three years has been far less than stellar.